827015-93-0 Usage
Content
PPAP is a chemical compound with a specific molecular structure.
Content
PPAP has potential psychoactive effects, meaning it can affect the brain and alter mental states.
Content
PPAP is derived from the naturally occurring compound indole, which is a key building block for various biological molecules.
Content
PPAP is structurally related to the neurotransmitter dopamine, which is involved in the regulation of mood, motivation, and reward.
Content
PPAP has been studied for its potential as a central nervous system stimulant, meaning it could potentially increase alertness and arousal.
Content
In animal models, PPAP has shown the ability to increase locomotor activity, which refers to the movement of animals in their environment.
Content
PPAP has been observed to increase dopamine levels in the brain, which could be related to its potential effects on mood and motivation.
Content
PPAP has been investigated for its potential use in the treatment of attention deficit hyperactivity disorder (ADHD) due to its effects on dopamine levels and locomotor activity.
Content
PPAP is also being studied as a potential antidepressant, possibly due to its effects on dopamine levels and mood regulation.
Content
More research is needed to fully understand the pharmacological properties and potential therapeutic applications of PPAP.
Check Digit Verification of cas no
The CAS Registry Mumber 827015-93-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,2,7,0,1 and 5 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 827015-93:
(8*8)+(7*2)+(6*7)+(5*0)+(4*1)+(3*5)+(2*9)+(1*3)=160
160 % 10 = 0
So 827015-93-0 is a valid CAS Registry Number.
827015-93-0Relevant articles and documents
SUBSTITUTED INDOLE LIGANDS FOR THE ORL-1 RECEPTOR
-
Page/Page column 46; 47, (2010/02/10)
New ligands for the ORL-1 receptor are described, useful for modulating the activity of said receptors in a patient in need thereof, and for preventing and treating illnesses dependent on the stimulation of this receptor. The new compounds conform to structural formula (I), wherein Q is a moiety of formula (II) and R, R0, R1, R2, R3, R4, R5, R6 are further defined in the description.
